In this webinar, we discussed the insights from our latest Medical Aesthetics Tracker; looking at what external factors influence patient decisions and choices to get certain treatment types. We touched upon: patient motivations, patient attitudes, and barriers to getting treatments.
The Changing Face of Medical Aesthetics.
25 May 2022
Download webinar presentation below
Key Takeaways
Adults who suffer from depression & anxiety are 42% more likely than the average UK adult to be considering aesthetics treatments in the next 12 months. HCPs and clinics need to consider this when dealing with their patients.
Our research shows that 76% of patients agree that it is important that the place they choose for their aesthetics treatment is CQC registered. This figure is a bit higher for prescription medicines and complex treatments.
In brand performance, we can see that 66% of botulinum toxin patients can recall the treatment brand used during their appointment. This includes brands such as, Azzalure, BOTOX, Boucouture and Alluzience.